Publication
Article
Pharmacy Times
Managing Adverse Events Related to SGLT2 Inhibitors: What a Pharmacist Needs to Know to Optimize Clinical Outcomes
Author(s):
This activity is supported by an educational grant from AstraZeneca LP.
Faculty
Daphne E. Smith Marsh, PharmD, CDE
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois at Chicago
Clinical Pharmacist
Ambulatory Pharmacy Services
University of Illinois at Chicago
Chicago, Illinois
Educational Objectives:
After completing this continuing education program, the participant will be able to:
- Identify which patients are most likely to benefit from SGLT2 inhibitor therapy.
- List common adverse effects of SGLT2 inhibitors.
- Review the counseling and monitoring needed to identify and minimize the adverse effects associated with the SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.
Target audience:
Pharmacists
Type of activity:
Knowledge
Release date:
April 7, 2015
Expiration date:
April 7, 2017
Estimated time to complete activity
: 2.0 hours
Fee:
Free
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-029-H01-P. The activity is available for CE credit through April 7, 2017.
